Accelerated Computational Drug Discovery

Built to support cross-disciplinary workflows, NVIDIA Clara™  Discovery combines the power of accelerated computing, AI, and machine learning to supercharge the entire drug development process, unlocking the potential to bring life-saving drugs to market faster.

Introducing MegaMolBART

The training framework for large chemical language models, MegaMoIBART achieves molecule generation at AI-supercomputing scale with high validity and uniqueness.

GPU-Powered Drug Discovery

Clara Discovery is a collection of frameworks, applications, and AI models

Apply AI and HPC to Drug Research

Clara Discovery is a collection of frameworks, applications, and AI models enabling GPU-accelerated drug discovery, with support for research in genomics, proteomics, microscopy, virtual screening, computational chemistry, visualization, clinical imaging, and natural language processing (NLP). Browse these tools in the NGC™ catalog, NVIDIA’s hub for GPU-optimized software.

Power Data-Driven Pharma R&D

Clara Discovery is optimized to run on NVIDIA DGX™ A100, the world’s most advanced AI system delivering five petaFLOPS of performance. Purpose-built for all accelerated computing workloads at scale, DGX A100 provides researchers the fastest time to solution and IT a unified, easy-to-deploy infrastructure to support the next-generation of drug discovery.

 View HPC Application Performance

 View Deep Learning Framework Performance

Full Stack Acceleration

Clara Discovery Partners

Sign up for the latest healthcare news from NVIDIA